Evidence map›Paper›PMID 28840820›Full record

ReviewMicrobiology spectrum2017

Ecological Therapeutic Opportunities for Oral Diseases.

Anilei Hoare, Philip D Marsh, Patricia I Diaz

Abstract readReview
In one paragraph

Review in Microbiology spectrum, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Effect of a Short-Term Intervention withInternational journal of environmental research and public health · 2022
    Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Review
  15. Article
  16. Mechanism of Action ofAntibiotics (Basel, Switzerland) · 2023
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anilei HoareDivision of Periodontology, Department of Oral Health and Diagnostic Sciences, UConn Health, Farmington, CT 06030.
Philip D MarshDivision of Oral Biology, School of Dentistry, University of Leeds, Leeds, United Kingdom.
Patricia I DiazDivision of Periodontology, Department of Oral Health and Diagnostic Sciences, UConn Health, Farmington, CT 06030.

Funding

The oral microbiome during cancer chemotherapy and its role in oral mucositisR01DE021578 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DIAZ, PATRICIA, DONGARI-BAGTZOGLOU, ANNA I · 2010 to 2013
$3.0M
In vitro models of subgingival communities and their in vivo pathogenic potentialR21DE023967 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DIAZ, PATRICIA · 2014 to 2015
$335k
NIDCR NIH HHS R01 DE021578NIDCR NIH HHS R21 DE023967
6 · The paper itself

Abstract

The three main oral diseases of humans, that is, caries, periodontal diseases, and oral candidiasis, are associated with microbiome shifts initiated by changes in the oral environment and/or decreased effectiveness of mucosal immune surveillance. In this review, we discuss the role that microbial-based therapies may have in the control of these conditions. Most investigations on the use of microorganisms for management of oral disease have been conducted with probiotic strains with some positive but very discrete clinical outcomes. Other strategies such as whole oral microbiome transplantation or modification of community function by enrichment with health-promoting indigenous oral strains may offer more promise, but research in this field is still in its infancy. Any microbial-based therapeutics for oral conditions, however, are likely to be only one component within a holistic preventive strategy that should also aim at modification of the environmental influences responsible for the initiation and perpetuation of microbiome shifts associated with oral dysbiosis.

Indexed as

Biological Control AgentsCandidiasis, OralDental CariesDysbiosisHumansMicrobiotaMouthPeriodontal DiseasesPhage TherapyProbioticsBiological Control Agents

Identifiers

PMID28840820
PMCPMC5573124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.